PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
1.340
-0.080 (-5.63%)
At close: Feb 21, 2025, 4:00 PM
1.440
+0.100 (7.46%)
After-hours: Feb 21, 2025, 6:04 PM EST
PDS Biotechnology Market Cap
PDS Biotechnology has a market cap or net worth of $50.13 million as of February 21, 2025. Its market cap has decreased by -69.98% in one year.
Market Cap
50.13M
Enterprise Value
25.05M
1-Year Change
-69.98%
Ranking
Category
Stock Price
$1.34
Market Cap Chart
Since October 1, 2015, PDS Biotechnology's market cap has decreased from $334.50M to $50.13M, a decrease of -85.01%. That is a compound annual growth rate of -18.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 50.10M | -17.87% |
| Dec 31, 2024 | 61.00M | -60.54% |
| Dec 29, 2023 | 154.60M | -58.92% |
| Dec 30, 2022 | 376.30M | 63.40% |
| Dec 31, 2021 | 230.30M | 383.82% |
| Dec 31, 2020 | 47.60M | 211.11% |
| Dec 31, 2019 | 15.30M | 51.49% |
| Dec 31, 2018 | 10.10M | -96.51% |
| Dec 29, 2017 | 289.20M | -20.00% |
| Dec 30, 2016 | 361.50M | 0.39% |
| Dec 31, 2015 | 360.10M | 7.65% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |